{"id":{"repo_id":"tenn-hsc","oai_identifier":"oai:dc.uthsc.edu:dissertations-1027"},"canonical_url":"https://search.dev.ndltd.org/etd/tenn-hsc/oai:dc.uthsc.edu:dissertations-1027","repository":{"repo_id":"tenn-hsc","name":"University of Tennessee Health Science Center","base_url":"https://dc.uthsc.edu/do/oai/"},"display":{"title":"The Biochemical Pathway Leading to Lpa Generation Upon Blood Coagulation","abstract":"<p>Platelet activation initiates an upsurge in 18:2 and 20:4 lysophosphatidic acid (LPA) production. The biochemical pathway responsible for LPA production during blood clotting is not fully understood. We have purified a phospholipase A<sub>1</sub> (PLA<sub>1</sub>) from thrombin-activated human platelets using sequential chromatographic steps followed by fluorophosphonate‑biotin affinity labeling and proteomics. We identified acyl‑protein thioesterase 1 (aka. lysophospholipase A1, accession code O75608) as a novel PLA<sub>1</sub>. Addition of this recombinant PLA<sub>1</sub> significantly increased the production of <em>sn</em>‑<em>2</em>‑esterified polyunsaturated LPCs and the corresponding LPAs in plasma. We next examined the regioisomeric preference of lysophospholipase D/autotaxin (ATX), which is the subsequent step in LPA production. To prevent acylmigration regioisomers of oleyl‑<em>sn</em>‑glycero‑3‑phosphocholine (LPAF) were synthesized. ATX preferred the <em>sn</em>‑<em>1</em> over the <em>sn</em>‑<em>2</em> regioisomer of LPAF. We propose the following LPA production pathway in blood: 1) Activated platelets secrete PLA<sub>1</sub>. 2) PLA<sub>1</sub>generates a pool of <em>sn‑2 </em>lysophospholipids. 3) These newly generated <em>sn‑2 </em>lysophospholipids undergo acyl migration to yield <em>sn‑1 </em>lysophospholipids, which are the preferred substrates of ATX. 4) ATX cleaves the <em>sn‑1 </em>lysophospholipids to generate <em>sn‑1 </em>LPA species predominant with 18:2 and 20:4 fatty acids.</p>","abstract_html":"&lt;p&gt;Platelet activation initiates an upsurge in 18:2 and 20:4 lysophosphatidic acid (LPA) production. The biochemical pathway responsible for LPA production during blood clotting is not fully understood. We have purified a phospholipase A&lt;sub&gt;1&lt;/sub&gt; (PLA&lt;sub&gt;1&lt;/sub&gt;) from thrombin-activated human platelets using sequential chromatographic steps followed by fluorophosphonate‑biotin affinity labeling and proteomics. We identified acyl‑protein thioesterase 1 (aka. lysophospholipase A1, accession code O75608) as a novel PLA&lt;sub&gt;1&lt;/sub&gt;. Addition of this recombinant PLA&lt;sub&gt;1&lt;/sub&gt; significantly increased the production of &lt;em&gt;sn&lt;/em&gt;‑&lt;em&gt;2&lt;/em&gt;‑esterified polyunsaturated LPCs and the corresponding LPAs in plasma. We next examined the regioisomeric preference of lysophospholipase D/autotaxin (ATX), which is the subsequent step in LPA production. To prevent acylmigration regioisomers of oleyl‑&lt;em&gt;sn&lt;/em&gt;‑glycero‑3‑phosphocholine (LPAF) were synthesized. ATX preferred the &lt;em&gt;sn&lt;/em&gt;‑&lt;em&gt;1&lt;/em&gt; over the &lt;em&gt;sn&lt;/em&gt;‑&lt;em&gt;2&lt;/em&gt; regioisomer of LPAF. We propose the following LPA production pathway in blood: 1) Activated platelets secrete PLA&lt;sub&gt;1&lt;/sub&gt;. 2) PLA&lt;sub&gt;1&lt;/sub&gt;generates a pool of &lt;em&gt;sn‑2 &lt;/em&gt;lysophospholipids. 3) These newly generated &lt;em&gt;sn‑2 &lt;/em&gt;lysophospholipids undergo acyl migration to yield &lt;em&gt;sn‑1 &lt;/em&gt;lysophospholipids, which are the preferred substrates of ATX. 4) ATX cleaves the &lt;em&gt;sn‑1 &lt;/em&gt;lysophospholipids to generate &lt;em&gt;sn‑1 &lt;/em&gt;LPA species predominant with 18:2 and 20:4 fatty acids.&lt;/p&gt;","abstract_has_math":false,"creators":["Bolen, Alyssa Lynn Jefferson"],"institution":null,"degree_name":"Doctor of Philosophy (PhD)","degree_level":"Dissertation","degree_discipline":"Biomedical Sciences","degree_department":null,"school":null,"contributors":["Gabor J. Tigyi, M.D., Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-05-01T07:00:00Z","date_published":"2011-05-01T07:00:00Z","updated_at":"2026-07-24T05:00:02Z","subjects":["Autotaxin","Lysophosphatidic acid","Phospholipase A1","Medical Cell Biology","Medical Molecular Biology","Medical Sciences","Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://dc.uthsc.edu/dissertations/27","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Gabor J. Tigyi, M.D., Ph.D."]},{"key":"dc:creator","label":"Author","values":["Bolen, Alyssa Lynn Jefferson"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2016-05-17T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Autotaxin","Lysophosphatidic acid","Phospholipase A1","Medical Cell Biology","Medical Molecular Biology","Medical Sciences","Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dc.uthsc.edu/dissertations/27"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Platelet activation initiates an upsurge in 18:2 and 20:4 lysophosphatidic acid (LPA) production. The biochemical pathway responsible for LPA production during blood clotting is not fully understood. We have purified a phospholipase A<sub>1</sub> (PLA<sub>1</sub>) from thrombin-activated human platelets using sequential chromatographic steps followed by fluorophosphonate‑biotin affinity labeling and proteomics. We identified acyl‑protein thioesterase 1 (aka. lysophospholipase A1, accession code O75608) as a novel PLA<sub>1</sub>. Addition of this recombinant PLA<sub>1</sub> significantly increased the production of <em>sn</em>‑<em>2</em>‑esterified polyunsaturated LPCs and the corresponding LPAs in plasma. We next examined the regioisomeric preference of lysophospholipase D/autotaxin (ATX), which is the subsequent step in LPA production. To prevent acylmigration regioisomers of oleyl‑<em>sn</em>‑glycero‑3‑phosphocholine (LPAF) were synthesized. ATX preferred the <em>sn</em>‑<em>1</em> over the <em>sn</em>‑<em>2</em> regioisomer of LPAF. We propose the following LPA production pathway in blood: 1) Activated platelets secrete PLA<sub>1</sub>. 2) PLA<sub>1</sub>generates a pool of <em>sn‑2 </em>lysophospholipids. 3) These newly generated <em>sn‑2 </em>lysophospholipids undergo acyl migration to yield <em>sn‑1 </em>lysophospholipids, which are the preferred substrates of ATX. 4) ATX cleaves the <em>sn‑1 </em>lysophospholipids to generate <em>sn‑1 </em>LPA species predominant with 18:2 and 20:4 fatty acids.</p>"]},{"key":"dc:title","label":"Title","values":["The Biochemical Pathway Leading to Lpa Generation Upon Blood Coagulation"]}]}],"canonical_facts":{"dc:contributor":["Gabor J. Tigyi, M.D., Ph.D."],"dc:creator":["Bolen, Alyssa Lynn Jefferson"],"dc:date.available":["2016-05-17T07:00:00Z"],"dc:description.abstract":["<p>Platelet activation initiates an upsurge in 18:2 and 20:4 lysophosphatidic acid (LPA) production. The biochemical pathway responsible for LPA production during blood clotting is not fully understood. We have purified a phospholipase A<sub>1</sub> (PLA<sub>1</sub>) from thrombin-activated human platelets using sequential chromatographic steps followed by fluorophosphonate‑biotin affinity labeling and proteomics. We identified acyl‑protein thioesterase 1 (aka. lysophospholipase A1, accession code O75608) as a novel PLA<sub>1</sub>. Addition of this recombinant PLA<sub>1</sub> significantly increased the production of <em>sn</em>‑<em>2</em>‑esterified polyunsaturated LPCs and the corresponding LPAs in plasma. We next examined the regioisomeric preference of lysophospholipase D/autotaxin (ATX), which is the subsequent step in LPA production. To prevent acylmigration regioisomers of oleyl‑<em>sn</em>‑glycero‑3‑phosphocholine (LPAF) were synthesized. ATX preferred the <em>sn</em>‑<em>1</em> over the <em>sn</em>‑<em>2</em> regioisomer of LPAF. We propose the following LPA production pathway in blood: 1) Activated platelets secrete PLA<sub>1</sub>. 2) PLA<sub>1</sub>generates a pool of <em>sn‑2 </em>lysophospholipids. 3) These newly generated <em>sn‑2 </em>lysophospholipids undergo acyl migration to yield <em>sn‑1 </em>lysophospholipids, which are the preferred substrates of ATX. 4) ATX cleaves the <em>sn‑1 </em>lysophospholipids to generate <em>sn‑1 </em>LPA species predominant with 18:2 and 20:4 fatty acids.</p>"],"dc:identifier":["https://dc.uthsc.edu/dissertations/27"],"dc:subject":["Autotaxin","Lysophosphatidic acid","Phospholipase A1","Medical Cell Biology","Medical Molecular Biology","Medical Sciences","Medicine and Health Sciences"],"dc:title":["The Biochemical Pathway Leading to Lpa Generation Upon Blood Coagulation"],"thesis:degree_discipline":["Biomedical Sciences"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-24T05:00:02Z"}